Home › Fatigue › Washington
Fatigue clinical trials in Washington
7 studies for Fatigue are looking for participants at sites in Washington.
Cities in Washington
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Arthritis Northwest PLLC, Spokane
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Washington State University Sleep and Performance Center, Spokane
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Sleep and Performance Research Center, Spokane
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07675135Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue
- Multiple Sclerosis Center at UW Medical Center - Northwest, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Mar 16, 2026 · NCT06809192Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
Recruiting
Ages 12 to 22 · All sexes · Updated Oct 30, 2025 · NCT06232304Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
- UW Medicine, Seattle
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 22, 2024 · NCT06270641From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.